Debarment Representation Sample Clauses

Debarment Representation. The Institution represents and warrants that neither the Institution nor the Principal Investigator nor any of the Study Staff is or ever has been debarred, disqualified, excluded, or suspended from participation in clinical research by any competent authority or agency in any country (including in particular, but without limitation, the Governmental Authority), and that it shall not make use of nor involve in this Study any person or organization which is or has been debarred, suspended, excluded, or disqualified by any competent authority to participate in clinical research. During the term of this Agreement and for three (3) years after its termination, in the event the Institution or the Principal Investigator or any person or organization involved in the Study is or becomes threatened with or becomes debarred, disqualified, suspended, or excluded during the Study, the Institution shall notify CRO in writing about this fact within five (5) days of its discovery. Prohlášení týkající se vyloučení. Zdravotnické zařízení prohlašuje a zaručuje se, že zdravotnické zařízení, hlavní zkoušející ani žádný z pracovníků studie není a ani nikdy nebyli vyloučeni, prohlášeni nezpůsobilými či vyřazeni z účasti na klinickému výzkumu, ani nebyla pozastavena jejich účast kompetentním orgánem či agenturou v jakékoliv zemi (zejména včetně, nikoliv výhradně, vládního úřadu) a že nepoužijí ani nezapojí do této studie žádnou osobu ani organizaci, která je nebo byla vyloučena, vyřazena či prohlášena nezpůsobilou k účasti na klinickém výzkumu nebo jejíž účast byla pozastavena libovolným kompetentním orgánem. Pokud bude v průběhu doby platnosti této smlouvy a po dobu tří (3) let po jejím ukončení zdravotnickému zařízení nebo hlavnímu zkoušejícímu nebo jakékoliv osobě nebo organizaci zapojené do studie hrozit vyloučení nebo bude-li tato osoba v průběhu provádění studie vyloučena, vyřazena či prohlášena nezpůsobilou, bude o tom zdravotnické zařízení písemně informovat CRO do pěti (5) dnů od data, kdy se o této skutečnosti dozví. Financial Disclosure. The Institution shall cause the Principal Investigator, and any sub-investigators employed in the performance of the Study to disclose to Sponsor and CRO the information regarding financial disclosures in a form provided by CRO. The Institution shall cause the Principal Investigator and sub-investigators to promptly update the information provided pursuant to this Section 11.4 if any relevant changes occur in the course of the Study o...
AutoNDA by SimpleDocs
Debarment Representation. The Site represents and warrants that neither the Site nor any of the Study Staff is or ever has been debarred, disqualified, excluded, or suspended from participation in clinical research by any competent authority or agency in any country (including in particular, but without limitation, the Governmental Authority), and that it shall not make use of nor involve in this Study any person or organization which is or has been debarred, suspended, excluded, or disqualified by any competent authority to participate in clinical research. During the term of this Agreement and for three (3) years after its termination, in the event the Site or any person or organization involved in the Study is or becomes threatened with or becomes debarred, disqualified, suspended, or excluded during the Study, the Site shall notify CRO in writing about this fact within five (5) days of its discovery.
Debarment Representation. As of the effective date of the applicable Engagement Letter and to the actual knowledge of the engagement principal, the Contractor represents to the best of its knowledge and belief, that it, its affiliates performing Services as subcontractors under the relevant Engagement, and its principals performing Services under the relevant Engagement a. Are not presently debarred, suspended, proposed for debarment, declared ineligible, or voluntarily excluded from covered transactions by any federal department or agency; 435400-P15-eHealth-Del-01

Related to Debarment Representation

  • Client Representations Client represents and warrants to Consultant that;

  • Investment Representation The Holder hereby represents and covenants that (a) any share of Stock acquired upon the vesting of the Award will be acquired for investment and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), unless such acquisition has been registered under the Securities Act and any applicable state securities laws; (b) any subsequent sale of any such shares shall be made either pursuant to an effective registration statement under the Securities Act and any applicable state securities laws, or pursuant to an exemption from registration under the Securities Act and such state securities laws; and (c) if requested by the Company, the Holder shall submit a written statement, in form satisfactory to the Company, to the effect that such representation (x) is true and correct as of the date of vesting of any shares of Stock hereunder or (y) is true and correct as of the date of any sale of any such share, as applicable. As a further condition precedent to the delivery to the Holder of any shares of Stock subject to the Award, the Holder shall comply with all regulations and requirements of any regulatory authority having control of or supervision over the issuance or delivery of the shares and, in connection therewith, shall execute any documents which the Board shall in its sole discretion deem necessary or advisable.

  • Defendant’s Representations The defendant acknowledges that he has entered into this plea agreement freely and voluntarily after receiving the effective assistance, advice and approval of counsel. The defendant acknowledges that he is satisfied with the assistance of counsel, and that counsel has fully advised him of his rights and obligations in connection with this plea agreement. The defendant further acknowledges that no threats or promises, other than the promises contained in this plea agreement, have been made by the United States, the Court, his attorneys or any other party to induce him to enter his plea of guilty.

  • Investment Representations (i) The Purchaser is acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable upon such exercise (collectively, the “Securities”), for the Purchaser’s own account, for investment purposes only and not with a view towards, or for resale in connection with, any public sale or distribution thereof.

  • Grievance Representation (A) An employee who decides to use this grievance procedure shall indicate at Step 1 (or other initial written step as authorized by the provisions of this Article) whether he shall be represented by the Union. If a grievant selects a Union Grievance Representative to represent him in a grievance which has been properly filed in accordance with this Article, the Union Grievance Representative may be allowed a reasonable amount of annual leave to investigate the grievance. Such annual leave shall be subject to prior approval by the Union Grievance Representative’s immediate supervisor; however, approval of such leave will not be withheld if the Union Grievance Representative can be allowed such time off without interfering with, or unduly hampering the operations of the unit to which the Union Grievance Representative is regularly assigned. When a grievant has elected Union representation, both the grievant and the Union Grievance Representative shall be notified of a Step 1 meeting. Written communication concerning the grievance or its resolution shall be sent to the grievant and the Union Grievance Representative, and the decision agreed to by the state and the Union shall be binding on the grievant.

  • False Representation Contractor understands, acknowledges, and agrees that any false representation or any failure to comply with a representation, warranty, or certification made by Contractor is subject to all civil and criminal consequences provided at law or in equity including, but not limited to, immediate termination of this Contract.

  • Company Representations (a) The Company is a corporation duly organized, validly existing and in good standing under the laws of the state of its incorporation, and has the power and authority to own, lease and operate its properties and carry on its business as now conducted.

  • Scope of Representation The scope of representation shall be limited to matters relating to wages, hours of employment and other terms and conditions of employment as defined in Government Code Section 3543.2. Nothing herein may be construed to limit the right of the District to consult with CSEA on any matter outside of the scope of representation.

  • UNION REPRESENTATION 3.01 For the purpose of representation with the Employer, the Union shall function and be recognized as follows:

  • Client Representations and Warranties You represent that you have the full legal power and authority to enter into this Agreement and that the terms of this Agreement do not violate any obligation or duty to which you are bound, whether arising out of contract, operation of law, or otherwise. If you are an entity (e.g., corporation, partnership, limited liability company, or trust), this Agreement has been duly authorized by the appropriate corporate or other action and when so executed and delivered shall be binding in accordance with its terms. You agree to promptly deliver such corporate resolution or other action authorizing this Agreement at our request. You acknowledge that you have provided us with the information set forth on the “Client Profile” (Exhibit C) and represent that such information is a complete and accurate representation of your financial position and of your investment needs, goals, objectives, and risk tolerance at the time of entering into this Agreement and warrant that you will promptly inform us in writing if and when such information becomes incomplete or inaccurate during the term of this Agreement. You also agree to provide us with any other information and/or documentation that we may request in furtherance of this Agreement or related to your investment needs, goals, objectives, and risk tolerance for the Account, either directly from you or through your designated attorney, accountant, or other professional advisers. You acknowledge that we are authorized to rely upon any information received from such attorney, accountant, or other professional adviser and are not required to verify the accuracy of the information.

Time is Money Join Law Insider Premium to draft better contracts faster.